Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome.
Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Check-Cap Ltd. (NASDAQ: CHEK) shares gained 38.3% to $2.67 in pre-market trading. Nobul AI Corp entered into business combination agreement with Check-Cap.
- C3is Inc. (NASDAQ: CISS) rose 35.2% to $0.0476 in pre-market trading. C3is is expected to release its fourth quarter financial results before the opening bell on March 26, 2024.
- OpGen, Inc. (NASDAQ: OPGN) gained 30.4% to $0.6196 in pre-market trading after the company announced David Lazar will invest $3 million in preferred stock and take over as CEO.
- Mesoblast Limited (NASDAQ: MESO) gained 23.2% to $2.71 in pre-market trading. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease.
- Intelligent Group Limited (NASDAQ: INTJ) shares rose 19.7% to $2.31 in pre-market trading after dipping around 9% on Monday.
- Krispy Kreme, Inc. (NASDAQ: DNUT) gained 16.3% to $14.48 in pre-market trading. McDonald's USA and Krispy Kreme announced expanded national partnership.
- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares rose 15.6% to $0.28 in pre-market trading after dipping 10% on Monday.
- Invivyd, Inc. (NASDAQ: IVVD) gained 13% to $3.65 in pre-market trading. Morgan Stanley analyst Maxwell Skor upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10.
- Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) climbed 10.3% to $0.1661 in pre-market trading after surging 24% on Monday. Greenwave Technology Solutions 13G filing showed Joseph Reda reported a 9.119% stake in the co as of March 22, 2024.
- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) dipped 54.5% to $0.4497 in pre-market trading after declining around 3% on Monday.
- AppTech Payments Corp. (NASDAQ: APCX) declined 35.8% to $1.06 in pre-market trading as the company disclosed a proposed underwritten public offering of common stock.
- Tivic Health Systems, Inc. (NASDAQ: TIVC) fell 20% to $1.16 pre-market trading after posting fourth-quarter results.
- BuzzFeed, Inc. (NASDAQ: BZFD) fell 12.5% to $0.3530 pre-market trading after the company posted downbeat results for its fourth quarter on Monday. The company also said it sees first-quarter overall revenues of $42 million to $44 million.
- Vivakor, Inc. (NASDAQ: VIVK) shares fell 12.2% to $0.7285 in pre-market trading. Vivakor shares fell around 7% on Monday after the company announced that it signed a definitive Membership Interest Purchase Agreement to acquire Endeavor Entities.
- Next.e.GO N.V. (NASDAQ: EGOX) shares tumbled 11.6% to $0.0450 in pre-market trading after jumping around 30% on Monday.
- Westport Fuel Systems Inc. (NASDAQ: WPRT) fell 10.5% to $6.47 in pre-market trading after posting a wider-than-expected fourth-quarter loss.
- Brera Holdings PLC (NASDAQ: BREA) fell 10.3% to $1.31 in pre-market trading.
- Dada Nexus Limited (NASDAQ: DADA) shares dropped 9.1% to $2.30 in pre-market trading after the company reported downbeat fourth-quarter results.
- GDS Holdings Limited (NASDAQ: GDS) fell 6.1% to $7.86 in pre-market trading following fourth-quarter results. GDS named Jamie Khoo as CEO of GDS International.
Now Read This: Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.